Olanzapine overdosePost injection delirium/sedation syndrome: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1651卷 / 1期
关键词：
D O I：
10.1007/s40278-017-30055-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：243 / 243
相关论文
共 50 条
  • [31] OlanzapinePost-injection delirium/sedation syndrome following drug overdose: case report
    Reactions Weekly, 2023, 1984 (1) : 413 - 413
  • [32] Olanzapine long-acting injection: post-injection delirium/sedation syndrome and cardiovascular disorders
    Bergdoll, E.
    Pinzani, V.
    Nishikawa, T.
    Grandvuillemin, A.
    Micallef, J.
    Trenque, T.
    Leplay, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 80 - 80
  • [33] OlanzapinePost injection delirium/sedation syndrome: 4 case reports
    Reactions Weekly, 2016, 1607 (1) : 315 - 315
  • [34] Olanzapine link to delirium/sedation after inadvertent intravascular injection
    Reactions Weekly, 2009, 1264 (1) : 4 - 4
  • [35] Post-injection delirium/sedation syndrome with olanzapine long-acting injections: case analysis and literature review
    Preve, M.
    Basaglia, C.
    Favaretto, E.
    Schifferle, I.
    Schwitzer, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S548 - S548
  • [36] OlanzapinePost-injection delirium and sedation syndrome: 2 case reports
    Reactions Weekly, 2022, 1889 (1) : 253 - 253
  • [37] OlanzapinePost-injection delirium sedation syndrome: 3 case reports
    Reactions Weekly, 2017, 1672 (1) : 207 - 207
  • [38] Analytically confirmed post-injection delirium/sedation syndrome (PDSS) after olanzapine long-acting injection
    Petrolini, Valeria M.
    Scaravaggi, Giulia
    Buscaglia, Eleonora
    Lambiase, Concettina
    Carbone, Maddalena
    Roda, Elisa
    Coccini, Teresa
    Locatelli, Carlo A.
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 428 - 429
  • [39] Post-Injection Delirium/Sedation Syndrome in Patients Treated with Olanzapine Pamoate: Mechanism, Incidence, and Management
    Daniel Luedecke
    Daniel Schöttle
    Anne Karow
    Martin Lambert
    Dieter Naber
    CNS Drugs, 2015, 29 : 41 - 46
  • [40] Post-Injection Delirium/Sedation Syndrome after Olanzapine Long-Acting Intramuscular Injection - Who is at Risk?
    Lukasik-Glebocka, Magdalena
    Sommerfeld, Karina
    Tezyk, Artur
    Panienski, Pawel
    Zaba, Czeslaw
    Zielinska-Psuja, Barbara
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (03) : 213 - 214
12345